Form D — OrbiMed Royalty & Credit Opportunities V, LP

0002041181-25-000001 · filed May 6, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings

Offering

Industry: Pooled Investment Fund
Exemptions: 06b, 3C, 3C.7
Reported offering amount: $1,750,000,000
Reported amount sold: $1,243,525,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: OrbiMed Royalty & Credit Opportunities V, LP
CIK: 2041181
Entity: Limited Partnership
Jurisdiction: DELAWARE
Year incorporated: 2024
Address: 601 LEXINGTON AVENUE, 54TH FLOOR
NEW YORK, NY 10022
Phone: 212-739-6400

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

N/A OrbiMed ROF V, LP · Executive Officer

New York, NY Find on LinkedIn ↗
N/A OrbiMed ROF V LLC · Executive Officer

New York, NY Find on LinkedIn ↗
N/A OrbiMed Advisors LLC · Executive Officer

New York, NY Find on LinkedIn ↗
David P. Bonita · Executive Officer

New York, NY Find on LinkedIn ↗
Sven H. Borho · Executive Officer

New York, NY Find on LinkedIn ↗
Carl L. Gordon · Executive Officer

New York, NY Find on LinkedIn ↗
Geoffrey C. Hsu · Executive Officer

New York, NY Find on LinkedIn ↗
W. Carter Neild · Executive Officer

New York, NY Find on LinkedIn ↗
Matthew S. Rizzo · Executive Officer

New York, NY Find on LinkedIn ↗
C. Scotland Stevens · Executive Officer

New York, NY Find on LinkedIn ↗
Peter A. Thompson · Executive Officer

New York, NY Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗